Introducing Koala Prospector! Bringing Waterfall Enrichment to Reps

Learn More!
Visikol

Visikol

Visikol is a contract research services company that is focused on accelerating drug discovery and development through the use of its imaging, digital pathology and advanced cell culture assay services. The company provides end-to-end preclinical services that include both 2D and 3D in vitro models and assays, 3D whole mount tissue imaging, multiplex imaging, high content imaging, digital pathology, and custom drug discovery solutions. Visikol's expertise is in transforming tissues and cells into large image-based data sets that can be mined for actionable insights such that pharmaceutical and biotech companies can make more quantitative and informed decision during the drug development process. Additionally, Visikol manufactures and sells a suite of tissue clearing reagents and 3D immuno-labelling kits. These products allow researchers to easily and rapidly image whole tissues and 3D cell culture models in 3D instead of traditional 2D sectioning.

Last updated on

About Visikol

Founded

2016

Estimated Revenue

$1M-$10M

Employees

11-50

Funding / Mkt. Cap

$5M

Category

Sector

Commercial Physical and Biological Research

Industry Group

Research, Development, and Testing Services

Industry

Biotechnology

Location

City

Hampton

State

New Jersey

Country

United States